World's Best Scientists 2026 revealed!
Pharmaceuticals
H-index 54

Pharmaceuticals

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 178 374 511 37
Medicine 532 363 421 33

Additional Metrics

Number of Best Scientists*: 1530
Documents by Best Scientists*: 1675
Top 100 Ranked Scientists*: 27
SCIMAGO H-index: 103
SCIMAGO SJR: 1.019
Impact Factor: 4.8

Overview

Top Research Topics at Pharmaceuticals?

Pharmacology, Internal medicine, Bioinformatics, Cancer research and Drug are among the topics commonly tackled in Pharmaceuticals. While Pharmacology is the focus of the journal, it also provided insights into the studies of Receptor and In vivo. The journal holds forums on Internal medicine that merges themes from other disciplines such as Gastroenterology, Endocrinology and Oncology.

The studies on Cancer research discussed can also contribute to research in the domains of Cancer cell and Cancer.

  • Pharmacology (21.07%)
  • Internal medicine (11.05%)
  • Bioinformatics (9.46%)

What are the most cited papers published in the journal?

  • Effect of Essential Oils on Pathogenic Bacteria (751 citations)
  • Human Antimicrobial Peptides and Proteins (271 citations)
  • Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer (258 citations)

Research areas of the most cited articles at Pharmaceuticals:

The published papers primarily tackle Pharmacology, Bioinformatics, Antimicrobial, Microbiology and Peptide. While the most cited publications focused on Pharmacology, they were also able to explore topics like Stroke, Receptor and Nitric oxide. While Bioinformatics is the key highlight in the journal papers, thet also covered some subjects on Cell and Intracellular.

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Pharmaceuticals (based on the number of publications) are:

  • Jean Jacques Vanden Eynde (11 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Roger Schibli (7 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Thomas Efferth (6 papers) published 3 papers at the last edition,
  • Guangshun Wang (6 papers) absent at the last edition,
  • Joachim Jose (5 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmaceuticals (based on the number of publications) are:

  • Spanish National Research Council (13 papers) published 9 papers at the last edition, 8 more than at the previous edition,
  • University of Porto (12 papers) published 5 papers at the last edition, 3 more than at the previous edition,
  • University of São Paulo (12 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • University of Milan (10 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • Katholieke Universiteit Leuven (10 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.84% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 8.89% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.39% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.79% of all publications and 67.92% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Antibody-Drug Conjugates: The Last Decade.

    Nicolas Joubert;Alain Beck;Charles Dumontet;Caroline Denevault-Sabourin

    (2020)
    325 Citations
  • Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment.

    Paula Garcia-Oliveira;Paz Otero;Antia Gonzalez Pereira;Antia Gonzalez Pereira;Franklin Chamorro

    (2021)
    264 Citations
  • Bone Tissue Engineering in the Treatment of Bone Defects

    (2022)
    180 Citations
  • Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery

    William M. Pardridge

    (2020)
    128 Citations
  • Identification of Novel Cyanopyridones and Pyrido[2,3-d]pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies

    (2022)
    124 Citations
  • Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources.

    Filipa Sousa;Domingos Ferreira;Salette Reis;Paulo Costa

    (2020)
    117 Citations
  • COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials

    Zhi-Peng Yan;Ming Yang;Ching-Lung Lai

    (2021)
    113 Citations
  • Strategies for Improving Peptide Stability and Delivery

    (2022)
    103 Citations
  • Antioxidant properties of second-generation antipsychotics: Focus on microglia

    Giuseppe Caruso;Margherita Grasso;Annamaria Fidilio;Fabio Tascedda

    (2020)
    94 Citations
  • The current and potential therapeutic use of metformin—the good old drug

    Józef Drzewoski;Markolf Hanefeld

    (2021)
    90 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond traditional medical degrees, there are several relevant online programs that complement a career in medicine. Pursuing the best online dha programs can prepare healthcare professionals for leadership roles by enhancing their management skills within medical settings.

Similarly, students looking to specialize in medication and pharmaceutical sciences may consider top-ranked online pharmacy schools. These programs offer flexible pathways for pharmacists seeking doctoral credentials to advance in clinical or research careers.

For those focused on the physical and rehabilitative aspects of healthcare, an online exercise science degree can provide foundational knowledge on human movement and wellness, essential for careers in physical therapy, fitness training, and sports medicine.

Additionally, accelerated programs like an accelerated kinesiology degree online offer a fast track into fields centered around body mechanics and injury prevention, making them a great choice for those seeking to complement their medical education with specialized training.

Best Scientists Contributing to This Journal

Recently Published Articles